510(k) Report

510(k) · Cleared

Cleared

Cardiva Catalyst Iii System with Protamine Sulfate

K082930510(k) TraditionalCleared Feb 13, 2009135-day reviewClass II21 CFR 870.4450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cardiva Medical, Inc. · DXC Clamp, Vascular

Cleared on Feb 13, 2009 as substantially equivalent to K072297 (Cardiva Medical, Inc., 2007) after a 135-day review. Its family tree reaches back 4 generations to 1992. 1 later device descends from it.

Decided
Feb 13, 2009
Review
135 days
Class
Class II
Product code
DXC
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K915280 (1992). 6 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor1997: 1 other ancestor2013: 1 descendant clearedK915280 · Femostop · Radi Medical Systems AB · 1992×2: 2 generations cleared close together, K051817 (2006), K070485 (2007) K072297 · Boomerang Catalyst/Boomerang Catalyst II System · Cardiva Medical, Inc. · 20071990200020102020
  1. Root · 4 generations backK915280 FemostopRadi Medical Systems AB · 1992
  2. 3 generations backK051817 Boomerang Closurewire Vascular Closure SystemCardiva Medical, Inc. · 2006
  3. 2 generations backK070485 Boomerang Wire /Boomerang Plus Wire System, Model# B Plus Wire 58LCardiva Medical, Inc. · 2007
  4. 1 generation backK072297 Boomerang Catalyst/Boomerang Catalyst II SystemCardiva Medical, Inc. · 2007
  5. This deviceK082930 Cardiva Catalyst Iii System with Protamine SulfateCardiva Medical, Inc. · 2009
  6. Descendant · cites it directly · 0 of its ownK130124 Catalyst II and IiiCardiva Medical, Inc. · 2013

Most influential descendants

Showing 1 of 1 · See all
  • K130124Catalyst II and IiiCardiva Medical, Inc. · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K915280FemostopRadi Medical Systems AB1992—
−3K051817Boomerang Closurewire Vascular Closure SystemCardiva Medical, Inc.2006—
−2K070485Boomerang Wire /Boomerang Plus Wire System, Model# B Plus Wire 58LCardiva Medical, Inc.2007—
−1K072297Boomerang Catalyst/Boomerang Catalyst II SystemCardiva Medical, Inc.2007—
0 (this device)K082930Cardiva Catalyst Iii System with Protamine SulfateCardiva Medical, Inc.2009—
+1K130124Catalyst II and IiiCardiva Medical, Inc.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
FIG. 1 — Lineage of K082930, 1992–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DXC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXC device

  1. #1 K262086 PreludeSYNC™ Radial Compression Devicescore 13.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K072297Boomerang Catalyst/Boomerang Catalyst II System
Summary page 1
…s II Product Code: DXC Trade Name: Cardiva CatalystTM III System Generic/Common Name: Vascular Clamp PREDICATE DEVICE Cardiva Medical BoomerangTM Catalyst II System (K072297) INTENDED USE The Cardiva CatalystTM III System with Protamine Sulfate is intended.to promote hemostasis at arteriotomy sites as…
Cardiva Medical, Inc.2007—

Also cleared against K072297: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K130124Catalyst II and IiiCardiva Medical, Inc.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 2 companies; a new generation was cleared every 1.4 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K130124 (Cardiva Medical, Inc., 2013) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K072297.

How does its category compare?

All DXC devices

DXC Clamp, Vascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · DXC

2in 2025

2007: 102008: 32009: 42010: 22011: 62012: 52013: 142014: 42015: 52016: 32017: 32018: 22019: 22020: 32021: 62022: 12023: 42024: 12025: 22026 (partial year): 4
2007high 14 (2013) · low 1 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXC

215in 2023

2007: 52 days median2008: 29 days median2009: 83 days median2011: 51 days median2012: 73 days median2013: 89 days median2014: 157 days median2015: 71 days median2016: 91 days median2017: 90 days median2020: 209 days median2021: 37 days median2023: 215 days median2026 (partial year): 125 days median
2007high 215 (2023) · low 29 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXC

2in 2023

2008: 22009: 22010: 12011: 32014: 12022: 12023: 2
2007high 3 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXC

442in 2025

2007: 2982008: 3022009: 5392010: 6002011: 6912012: 5482013: 9202014: 4942015: 3742016: 4942017: 4162018: 3912019: 3932020: 4042021: 3712022: 2732023: 6742024: 3752025: 442
2007high 920 (2013) · low 273 (2022)2025

MAUDE reports naming product code DXC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200710520298
20083292302
20094832539
20102—1600
20116513691
20125730548
201314890920
201441571494
20155710374
20163910494
20173900416
20182—0391
20192—0393
202032090404
20216370371
20221—1273
202342152674
20241—0375
20252—0442
202641250—

What is it indicated for?

The Cardiva CatalystTM III System with Protamine Sulfate is intended to promote hemostasis at arteriotomy sites as an adjunct to manual compression in heparinized patients. The Cardiva CatalystTM III System is indicated for use in patients undergoing diagnostic and/or interventional femoral artery catheterization procedures using 5F, 6F or 7F introducer sheaths.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K082930: Cardiva Catalyst Iii System with Protamine Sulfate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K082930

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026